UBS AM
BLU

UBS AM’s BELLUS Health Inc. BLU Stock Holding History

UBS AM’s Portfolio BLU Stock Details BLU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-31,100
Closed -$70.8K – 2600
2020
Q3 		$70.8K Hold
31,100
– – ﹤0.01% 2474
2020
Q2 		$321K Buy
+31,100
New +$315K ﹤0.01% 2260

Other funds holding BLU

Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM

UBS AM's BLU Position: Q4 2020 in Review

UBS AM sold out of BELLUS Health Inc. (BLU) in Q4 2020, closing a stake of 31,100 shares — an estimated $70.8K sold.

UBS AM first reported a position in BLU in Q2 2020 and held it in 2 quarters. The position peaked at $321K in Q2 2020. 46 funds tracked by Wall St. Rank hold BLU as of Q4 2020.

  • UBS AM reported no remaining BELLUS Health Inc. position as of Q4 2020 after selling out during the quarter.
  • UBS AM sold 31,100 BELLUS Health Inc. shares in Q4 2020, an estimated $70.8K.
  • UBS AM first reported a position in BELLUS Health Inc. in Q2 2020 and held it in 2 quarters.
  • UBS AM's BELLUS Health Inc. position peaked at $321K in Q2 2020.
  • 46 funds tracked by Wall St. Rank held BELLUS Health Inc. as of Q4 2020.

Based on UBS AM's 13F filing for Q4 2020, filed 17 Feb 2021.